Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is founded in 1994, and in Jul 1998 it successfully got listed in Shanghai Stock Exchange (Stock NO. 600196).

Focused on modern bio-medicine & health-care industry, Fosun Pharma has formed its core competences in R&D, marketing, M&A, and HR management after years of development, and now it is a large professional pharmaceutical group, mainly in medicine research and manufacturing, with leading market share in medicine distribution, diagnostic products and medical equipments.

Fosun is the biggest supplier of Arteminsinin-based antimalaria drugs in China. It currently holds six pharmaceutical companies providing varieties of finished drug products, APIs and other pharmaceutical materials.

Fosun's product portfolio includes:

Antimalaria and anti-parasitic drugs and APIs
Amio Acids (APIs)
Anti-infection drugs and APIs
APIs for Nervous System Disease
Nutrients and nutritional supplements
Sourcing services